A Study to Test Whether Nintedanib Influences the Components of Birth-control Pills in Women With Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Clinical trial NCT03675581 · COMPLETED
Trial details
- NCT number
- NCT03675581
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-08
- Primary completion
- 2019-10-09
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.